Skip to Main Content
Don't have an account? Create Account
Don't have an account? Create Account

On the Hill: House Hearings on 340B, Insurance Alternatives

The House Committee on Energy and Commerce last week held a two-panel hearing focused on the 340B Drug Pricing Program.

The first panel included a witness from the Government Accountability Office (GAO) who focused on the latest GAO report on 340B contract pharmacies. The panel reviewed recommendations the agency made to the Health Resources and Services Administration on monitoring the 340B program.

The second panel included stakeholders and reviewed 15 bills aimed at improving the 340B program, as well as the growth, transparency, and intent of the program. America’s Essential Hospitals issued an Action Alert with more information on the bills that were discussed in the hearing.

Two essential hospital leaders testified as key witnesses: Frederick Cerise, MD, MPH, president and CEO of Parkland Health & Hospital System, in Dallas; and Charles Daniels, PhD, pharmacist-in-chief and associate dean of the University of California-San Diego.

Ways and Means Markup

Meanwhile, the House Committee on Ways and Means last week  held a full committee markup on several consumer-driven health care bills, specifically focused on expanding health savings accounts and exploring alternative insurance plans. The markup included a controversial bill, H.R. 4616, which would postpone for an additional year both the Affordable Care Act’s employer mandate and the Cadillac tax. H.R. 4616 passed out of the committee, and it is uncertain whether it will be brought to the House floor.

Additional Committee Activity 

Three congressional panels will have hearings on July 17:


About the Author

Erin Delaney is a former legislative affairs associate at America's Essential Hospitals.

Previous Next
Test Caption
Test Description goes like this